Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, October 31, 2026

Back to today

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet 2027 debt maturities.

ABR $2.2B
John Hempton's Newsletter 3 clicks

From X

@ParadisLabs

Paradis on X

Personal dip buys from today: $AVGO, $MRVL, $KLAC $AVGO: - Feels like the market has overlooked Broadcom YTD. - I think they're still one of the best positioned in the networking theme thanks to exposure to many diverse areas - optical DSP, Tomahawk, Jericho. - Future growth should accelerate via Tomahawk 6/7 ramping in 2027, Tomahawk Ultra, optical DSPs. - Obviously there are risks with Broadcom but I ultimately see earnings upside = stock should re-rate (at some point lol). $MRVL: - Investor day last week basically confirmed that they're a scaleable AI infra name...not just custom silicon / DSP. - Feels like Marvell's opportunity is now much bigger than most people thought. - E.g. other than 800G/1.6T....NPO/CPO, and scale-out + up. - Still think it's early from them with many areas yet to ramp volumes e.g. 1.6T and NPO/CPO. Overall, feels like both Broadcom and Marvell are very well positioned. Broadcom keep adding XPU customers + extend those deals with hyperscalers. Marvell keep growing, very high torque right now IMO. $KLAC: - Down 42% in 3.5 months and haven't had a position before and wanted to take one lol - more so as a re-rating trade rather than a longer-term hold. - No real in depth thesis, more so a risk/reward play in the broader "AI quality" ecosystem I'm tracking. - Especially when compared against other semicaps like $LRCX / $AMAT that are well ahead in YTD %. Obviously these aren't your sexy names like $NBIS, $INTC or $BE - but I feel like I built my positions in these types of names earlier in the year (was a little late to the Intel party) and don't want my core portfolio to get overly concentrated. That said, I'm well aware that semis earnings are right around the corner and that many of these bottleneck type names have de-rated. But as of right now, I'm sitting slightly on the cautious side by not attempting to time bottoms here. Recent flow data has been tragic for semis, so would rather wait to see a few days of +ve net flows first to get some confidence that investor fatique isn't a permanent scar. There's only so much tolerance investors have for multiple >20% drawdowns in a matter of months.
@aleabitoreddit 3 clicks

Serenity on X

Glad we finally got a word too from $NVDA Jensen Huang today from an event at Stockholm... About $CRWV amid the broader Neocloud selloff. When asked about the markets reactions to Coreweave, Jensen responded: - "Coreweave's strength is improving every day, I'm optimistic" - "The cost of capital is actually decreasing" On whether Nvidia needed to provide a financial backstop: - Jensen said he did not see a need for Nvidia to backstop CoreWeave I'm personally not too positive about $CRWV relative to $NBIS and the others... but any copium helps from the man himself with market sentiment.
@stockgutter 1 click

SG on X

I had someone pull the audio and had it electronically transcribed. There was one sentence that was along the lines you describe: "Papaya respectfully disagrees with the judgment rendered in that SDNY case. It's appealing that judgment while at the same time planning to find a way to pay in full whatever the final amount may be." To me that is hardly an assurance. I think they pay a good part of it eventually, but only with their feet to the fire. $FIRY

Investor Letters

All letters

FTAI 3Q26: Aero margins in focus

FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…

FTAI $20B
Stock Thoughts 4 clicks

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

CVX $423B
Cestrian Capital Research 3 clicks

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $114B
Cestrian Capital Research 1 click
PSN · long

Parsons CORP

Parsons generates roughly half of its $6.4 billion revenue from Federal Solutions, serving defense and intelligence customers.

PSN $5.6B
Value Investors Club

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

SOFI $22B
WHAT ARE WE DOING? “Contrarians At The Gate” 3 clicks

Intel Q3 2026: Dead Inside

Intel’s Q3 2026 datacenter CPU shortage reflects wafer-start planning failures, not substrate constraints, after demand shifted from client…

INTC $348B
Irrational Analysis 2 clicks

INTC Q3 FY12/26 Earnings Review

Intel's Q3 revenue rose 21% to $16.5 billion, led by 78% data-center and AI growth, but Q4 guidance of $15.5 billion trailed consensus.

INTC $348B
Cestrian Capital Research 4 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 73 of 273

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

286 firms

Sectors

Ordered by how often our editor reaches for them.